US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
(OP:
NDOI
)
23.59
UNCHANGED
Last Price
Updated: 1:24 PM EDT, Jul 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NDOI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NDOI, SSBK, BRDG on Behalf of Shareholders
May 18, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI
May 16, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBT, NDOI, RDFN on Behalf of Shareholders
May 03, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI
March 14, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Mallinckrodt, Endo Merger To Create Pharma Entity Valued At $7 Billion
↗
March 13, 2025
Mallinckrodt and Endo are merging in a $6.7 billion deal, with a pro forma NYSE listing and $900 million in financing.
Via
Benzinga
NDOI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Endo, Inc. Is Fair to Shareholders
March 13, 2025
From
Halper Sadeh LLC
Via
Business Wire
Shareholder Alert: The Ademi Firm Investigates Whether Endo, Inc. Is Obtaining a Fair Price for Its Public Shareholders
March 13, 2025
From
Ademi & Fruchter LLP
Via
Business Wire